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Background: The APOBEC3 (A3) genes play a key role in innate antiviral defense in mammals by introducing
directed mutations in the DNA. The human genome encodes for seven A3 genes, with multiple splice alternatives.
Different A3 proteins display different substrate specificity, but the very basic question on how discerning self from
non-self still remains unresolved. Further, the expression of A3 activity/ies shapes the way both viral and host
genomes evolve.
Results: We present here a detailed temporal analysis of the origin and expansion of the A3 repertoire in
mammals. Our data support an evolutionary scenario where the genome of the mammalian ancestor encoded for
at least one ancestral A3 gene, and where the genome of the ancestor of placental mammals (and possibly of the
ancestor of all mammals) already encoded for an A3Z1-A3Z2-A3Z3 arrangement. Duplication events of the A3
genes have occurred independently in different lineages: humans, cats and horses. In all of them, gene duplication
has resulted in changes in enzyme activity and/or substrate specificity, in a paradigmatic example of convergent
adaptive evolution at the genomic level. Finally, our results show that evolutionary rates for the three A3Z1, A3Z2
and A3Z3 motifs have significantly decreased in the last 100 Mya. The analysis constitutes a textbook example of
the evolution of a gene locus by duplication and sub/neofunctionalization in the context of virus-host arms race.
Conclusions: Our results provide a time framework for identifying ancestral and derived genomic arrangements in
the APOBEC loci, and to date the expansion of this gene family for different lineages through time, as a response to
changes in viral/retroviral/retrotransposon pressure.
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Cytidine deaminases of the APOBEC3 (A3) gene family
have a broad antiviral activity against retroviruses, can in-
hibit LTR- and non-LTR-retrotransposons, parvoviruses,
hepadnaviruses, flaviviruses and paramyxoviruses, and
might repress also TT-viruses, papillomaviruses and her-
pesviruses [1-9]. Under the already tested additional
viruses, adenoviruses, poxviruses and influenza viruses
replicate well irrespective of A3s [3,10,11]. The hunt is on
for the identification of additional viral targets [12]. The* Correspondence: igbravo@iconcologia.net
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reproduction in any medium, provided the orAPOBEC3 gene family encodes a characteristic zinc (Z)-
coordinating catalytic motif (His-X-Glu-X23–28-Pro-Cys-
X2–4-Cys) [13] and the A3 proteins can be classified
according to the presence of an A3Z1, A3Z2 or A3Z3
motif [14-16]. A3s act by deaminating cytidine into uridine
(EC 3.5.4.5) using single-stranded DNA as a substrate.
This DNA editing results in the introduction of mutations
that eventually render the target genome inactive. How-
ever, uncontrolled chemical editing of DNA sequences
puts at risk the genomic information in the cell [17,18]
and many mechanistic questions regarding A3 activity and
substrate specificity remain open.
During retroviral budding, A3 molecules incorporated
into progeny retroviral particles are carried over within
the virion and counteract the new infection upon release
in the cytoplasm of the newly infected cell. Retrovirusestd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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A3s into viral particles. The Vif protein in lentiviruses,
the Bet protein in foamyviruses and the nucleocapsid
protein in Human T-cell lymphotrophic virus accomplish
this anti-antiviral activity [19-24]. The expression of A3s
is not restricted to the immune system [25], and differ-
ent cell types may express different A3 repertoires, and
even different variants may present different subcellular
location [26]. Thus, some retroviruses without vif or bet
genes might escape A3-mediated antiviral inhibition by a
restriction of their cellular tropisms, as it is discussed for
the Equine infectious anemia virus [27]. Several aspects
on how retroviruses cope with the deaminase activity of
the A3s encoded by their host species are still a matter
of debate [28,29]. Thus, and despite several studies, it
remains unknown which strategies the Moloney murine
leukemia virus or the Mouse mammary tumor virus have
evolved to prevent inhibition by the murine A3 [30-36].
In mammals the A3 locus appears always flanked by the
CBX6 and CBX7 genes but there is ample variation across
species, regarding the number and arrangement of A3 indi-
vidual genes, presence of fused genes, expression pattern,
splice alternatives and read-through mechanisms and sub-
strate specificity, even in related species. Thus, although
Primates and Rodents are relatives and belong together
within Euarchontoglires, the human genome contains
seven A3 genes, four of them resulting from the fusion of
two A3 domains, while the mouse genome encodes for a
single A3Z2-A3Z3 fused gene [37]. Additionally the dog
genome presents two A3 genes, while there are four A3
genes in cats, two to three in pigs, sheep and cow and six
in horses [15,16,27], and all these species belong together
within Laurasiatheria. The finding of A3Z1, A3Z2, and
A3Z3 genes in these two mammalian lineages strongly
indicates that their ancestor (Boreoeutheria) was probably
equipped with a single copy of each gene.
One important mechanism of genome evolution and for
the appearance of novel gene functions is gene duplication
[38]. Genes within a genome that are descendants of gene
duplications are paralogs, while two genes in different spe-
cies that derive from a single gene in the last common an-
cestor of both species are orthologs. Paralogs derive either
from an ancestral duplication (“outparalogs”) or they de-
rive from a lineage-specific duplication (“inparalogs”), giv-
ing rise to co-orthologous relationships [39]. Several
models for the emergence, maintenance and evolution of
gene copies have been proposed (for a review see [40]).
The duplication of genes may in some cases have no im-
mediate consequence for the host, but in other cases can
be deleterious or linked to disease [41], or confer an select-
ive advantage [42]. For the antiviral A3 genes evolutionary
solutions reflect the trade off between a potential self-
toxicity against cellular DNA -in cases of an A3 exacer-
bated response- and the emergence of viral pathogens iflow A3 activity and/or diversity allow for restriction escape
variants. Fixation of duplicated A3 genes and the subse-
quent preservation in certain population is likely driven by
a strong selective advantage for the individuals carrying
additional copies of the gene/s. Any subsequent acquisi-
tion of genetic differences between the gene copies can
alter the chances of both copies being preserved and
might change the function of the encoded proteins and re-
sult either in gene loss, ‘neo-functionalization’ [38] or ‘sub-
functionalization’ [43].
We present here a time scale of the evolution of the A3
loci, arising from their common origin with other cytidine
deaminases. According to our results, the track of duplica-
tions in the A3 locus started with the ancestral gene itself.
The appearance of the three clades within the A3 family
dates back to emergence of placental mammals. The evo-
lutionary history of A3s has since then been landmarked
by duplication events especially in Primates, but also in
Perissodactyla and Carnivora, as well as by deletions
events, such as in Rodentia. Three main trends can be
observed: first, a sustained decrease in evolutionary rate
for the A3 subfamilies in the last 100 Mya; second, dupli-
cation events have occurred in the A3Z1 and A3Z2 sub-
families, but not in the A3Z3; third, duplication events
accumulate in the last 50 Mya. The molecular mechan-
isms that generate the tandem duplication of A3, and the
evolutionary pressures that drive the sub/neofunctionalisa-
tion and eventually selection of the duplicated genes still
need to be identified.
Results
There are three main clades of A3 genes
We have found sequences corresponding to A3 genes in
extant members of Laurasiatheria (seven Carnivora, seven
Cetartiodactyla, one Perissodactyla and one Chiroptera
species), Euarchontoglires (three Rodentia and seventeen
Primates species) and Afrotheria (one Hyracoidea and one
Proboscidea species). However, BLAST and PSI-BLAST
searches of genomic, EST and other sequence databases
failed to find A3 in any other taxon within other placental
mammals (e.g. Xenarthra) marsupials, monotremes, or in
non-mammals. A selection of 34 AICDA sequences (23
Eutheria species, three Metatheria, one Prototheria, two
Aves, two Amphibia and three Actinopterygii species) was
identified as sister taxa to all A3s, while a selection of 24
A1 sequences (21 Eutheria species, two Metatheria and
one Aves species) was identified as outgroup. An exhaust-
ive list of species and accession numbers is given in
Additional file 1: Table S1. Using this dataset, we
performed first phylogenetic reconstruction using both
maximum likelihood and Bayesian inference, identified
local topologies suitable for molecular dating, and then
performed time inference introducing this information as
temporal constrains using a relaxed clock approach. The
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are shown in Additional file 2: Figure S1 which shows the
bootstrap values of the ML analysis and Additional file 3:
Figure S2 which contains the 95% highest posterior dens-
ity (HPD) of the node ages.
The most recent common ancestor (MRCA) of the A1s,
A3s and AICDA sequences can be dated 441 Mya (95%
HPD, 431–456 Mya). The MRCA of the A3s and AICDA
sequences can be dated 424 Mya (95% HPD, 417–438
Mya), while the MRCA of extant A3 sequences can be
dated 247 Mya (95% HPD 193–351 Mya) (Figure 1). The
three members of the A3 family radiated later at compar-
able time points: 112 Mya (95% HPD 109–113 Mya) for
A3Z1; 111 Mya (95% HPD 106–113 Mya) for A3Z2; and
109 Mya (95% HPD 102–113 Mya) for A3Z3. The rela-
tionships among the three A3 subfamilies could not be
solved with certainty, but both ML (44% bootstrapFigure 1 Dated Bayesian phylogenetic tree for the A3 family using A1
nodes correspond to ML bootstrap support. Error bars encompass 95% HPD
the corresponding lineage and moment in time. Clock cartoons labels the
colours (code in the inset). No sequences from Xenarthra could be found isupport) and Bayesian inference (0.52 Bayesian posterior
probability) suggested a sisterhood relationship between
A3Z1 and A3Z2, with a MRCA dated 199 Mya (95% HPD
164–251 Mya). Only more quality data from Afrotheria,
or the discovery of A3 genes in Monotremes, Marsupials
and/or Xenarthra may help us define and date these basal
nodes with confidence.
Evolution of the A3 loci in Euarchontoglires
Rodents and Primates are the two main orders in Euarch-
ontoglires. We could identify different A3 genes in the
genomes of platyrrhines (New World monkeys) and catar-
rhines (Old World monkeys and apes). In modern humans
eleven A3 open reading frames exist, forming seven genes
encoding a single Z domain or a Z-Z domain, either fused
A3Z2-A3Z2 or A3Z2-A3Z1 (Figure 2). This is by far the
most complex known organisation of the A3 loci. Wesequences as outgroup. Scale bar given in Mya. Values at the
for the age of the nodes. Star symbols indicate duplication events in
nodes used for calibration. Mammalian clades are labelled using
n our searches.
Figure 2 Projection of the A3 phylogenetic relationships onto the human genomic locus. Exon composition and gene arrangement of the
seven A3 genes are displayed. Labels indicate median age [95% HPD] of the corresponding nodes. Several milestones in the evolution of
mammals are indicated.
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structure of the A3 loci in other primate genomes, espe-
cially regarding transcriptomic data, is still fragmentary.
A3Z1 genes in primates
The A3Z1 gene appears in humans in three copies,
named Z1a, Z1b and Z1c, and we will name the corre-
sponding orthologs according to the nomenclature in
humans (Figure 2). The MRCA of A3Z1 genes can be
dated 71 Mya (95% HPD 60–84), which grossly corre-
sponds to the basal divergence time of primates, some
73–87 Mya. Orthologs of the A3Z1 genes can be found
in the genomes of several Haplorrhini species, including
Catarrhini (Old World monkeys and apes) and Platyr-
rhini (New World monkeys). We could only detect one
A3Z1 gene in the platyrrhines genomes we have
browsed, and these sequences are the outgroup of the
Z1a, Z1b and Z1c found in catarrhines. Phylogenetic
relationships and inferred divergence times among the
Z1c orthologs grossly correspond to those among thecorresponding species. Regarding the Z1a and Z1b
genes, we could identify the orthologs of both human
genes in the genomes of the common chimpanzee, west-
ern gorilla, northern white-cheeked gibbon and Rhesus
macaque. The ortholog of the Z1b human gene could be
identified in the Sumatran orangutang. The duplication
event that generated the Z1a and Z1b genes can be
dated some 27 Mya (95% HPD 22–32). This timing
could be compatible with the Hylobatidae/Hominidae
split some 18–24 Mya, although it matches well the Cer-
copithecidae/Hominoidea split some 26–34 Mya [44].
A plausible scenario for the evolution of the A3Z1 loci
in primates would include a basal split, generating the
ancestors of the Z1a/Z1b (hereafter Z1ab) and the Z1c
genes. Whether this first duplication event predates the
early split Haplorrhini (tarsiers, monkeys and apes)/Strep-
sirrhini (non-tarsier prosimians) or is rather exclusive to
the Haplorrhini lineage is not clear and must still be
solved, since there are no sequence data available for
Strepsirrhini. In Catarrhini, the ancestral Z1c gene may
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cestral Z1ab gene underwent duplication and generated
the ancestral Z1a and Z1b genes. Orthologs of both Z1a
and Z1b are present in all hominids [45], as the MRCA to
both genes predates well the split Ponginae/Homininae.
Future identification of Z1ab genes in hylobatids and in
cercopithecoids will clear whether the Z1a/Z1b duplica-
tion event is basal to catarrhini or to Hominoidea.
A3Z2 genes in primates
Our fragmentary information on the A3 gene content
makes it impossible to reconstruct with confidence the
evolutionary relationships among the A3Z2 genes in pri-
mates. Additionally, a number of A3Z2 sequences arise
from genomic material while others belong to cDNA, and
the complex alternative splicing of the A3 genes may dis-
turb further the algorithms for phylogenetic inference. Fi-
nally, in this locus gene conversion may have played a key
role, given the large number of gene duplication events in
this A3 subfamilly -up to six in humans- and the nature of
the locus, where the copies generated remain in a tandem
arrangement. A proper phylogenetic reconstruction will
thence need to wait until genomic sequences with better
coverage are available for a larger number of primate spe-
cies, especially if encompassing Strepsirrhini and Tarsiidae.
A basal split event some 94 Mya (95% HPD 89–99) gener-
ated the two main lineages Z2bdf and Z2aceg. This timing
could match the basal strepsirrhini/haplorrhini diversifica-
tion time in primates (some 87 Mya), although it would be
more compatible with one duplication exclusive to haplor-
rhini (MRCA some 85 Mya) or even to simiiformes. In ei-
ther case our interpretation implies that the ancestral
simiiformes already carried two copies of the A3Z2 genes
in their genomes. The Z2bdf group comprises exclusively
sequences from catarrhines, with an estimated MRCA
around 43 Mya (95% HPD 35–54). Sequences here cluster
into two groups: Z2b and Z2df. Both clusters contain
sequences from cercopithecoids and from hominoids. It
can thus be inferred that the duplication event that gener-
ated both groups took place before the divergence be-
tween cercopithecoids and hominoids some 29 Mya. This
timing is compatible with the estimated MRCAs around
28 Mya (95% HPD 23–34) for Z2b and 32 Mya (95% HPD
28–34) for Z2df. Within the Z2aceg group, phylogenetic
inference cannot solve the fine relationships. Only a major,
monophyletic group containing the Z2g genes can be
clearly defined, containing sequences of both catarrhines
and platyrrhines. Phylogenetic relationships among Z2g
genes grossly correspond to those of the corresponding
species: platyrrhines are basal to the cluster, with calcu-
lated split time 39 Mya (95% HPD 34–45), and cercopithe-
coids and hominids cluster separately, with a MRCA
around 24 Mya (95% HPD 23–28).A plausible scenario for the evolution of the A3Z2 genes
in primates would include a first basal split Z2aceg/Z2bdf,
previous to the split between platyrrhini and catarrhini.
The ancestral Z2aceg underwent a second duplication
Z2ace/Z2g also before this split event. Modern Z2a, Z2c
and Z2e human genes appeared after subsequent duplica-
tion events. On the other hand, the ancestral Z2bdf under-
went a first duplication Z2b/Z2df at least before the
divergence between cercopithecoids and hominoids. The
basal position of human Z2d with respect to Z2f
sequences suggests also that the duplication event Z2d/
Z2f predates diversification within catarrhines, but a larger
repertoire of sequences is needed here to reconstruct
phylogenetic relationships with confidence.
A3Z3 genes in primates
Orthologs of the A3Z3 gene can be found in the genomes
of the catarrhines chimpanzee, bonobo, human, gorilla,
Bornean and Sumatran orangutan, gibbon and macaque
(Figure 1). The MRCA of these A3Z3 genes dates back to
31 Mya (95% HPD 26–34). In all these species the A3Z3
gene appears as a single copy, with no evidences of gene
duplication. Additionally, the phylogenetic relationships
among these genes and the inferred timing for the nodes
perfectly match those of the corresponding species. The
most parsimonious explanation for the absence of A3Z3
in platyrrhines and in other primates is therefore our lack
of information about the locus, and it can be anticipated
that the missing A3Z3 genes should be identified in the
future, as genome coverage increases.
A3 genes in rodents
In the rodent Cavia porcellus, as in rat and mouse, the
Z2Z3 genes are fused and the A3Z1 gene is missing.
Considering the presence of A3Z1 in Primates, the last
common ancestor of Muridae and Caviidae probably
possessed already 50–85 Mya the genome organization
found in the extant rat and mouse genomes. Precise
answers on the timing for the A3Z1 deletion event and
for the Z2Z3 fusion event will need to wait until new
genomic information is available. Interesting sequences
could come from the genomes of squirrels, which are
basal to Muridae/Caviidae, or from rabbits, which con-
stitute together with rodents the Glires taxon, sister to
Primates.
Evolution of the A3 loci in Laurasiatheria
A3 genes in cetartiodactyla
In the group of Cetartiodactyla (even-toed ungulates)
the evolution of the individual A3 genes matches the
evolution of the host genomes (Figure 1), although there
is controversy about the phylogenetic relationships
among mammalian orders here [46]. The genomes of
cow and sheep present single copies of the A3Z1, A3Z2
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tions. In the A3 locus in the pig, the A3Z1 gene however
seems to have been lost during evolution [15,47]. The
presence of a A3Z1 gene in the genomes of cow and
sheep suggests that the loss of the A3Z1 gene in pig gen-
ome occurred after the split that generated the Suidae
lineage.
A3 genes in horses
Modern horses have six A3 genes (Z1a, Z1b, Z2a, Z2b,
Z2c, Z2d, Z2e, A3Z3) [27,48], which arose from the an-
cestral A3Z1, A3Z2 and A3Z3 genes after relatively re-
cent duplication events (Figure 3a). The A3Z1 locus in
the horse genome experienced a duplication event ca. 64
Mya (95% HPD 44–79), whereas the A3Z2 locus under-
went three rounds of expansion between 39 and 18 Mya.
The phylogenetic relationships as well as the accord in
timing for the last two duplications suggest that the tan-
dem of ancestral Z2ac and Z2bd genes underwent dupli-
cation in a single step, generating the present day
arrangement Z2a Z2b Z2c Z2d Z2e [27]. The Equus
genus dates back to ca. 4 Mya, posterior to the duplica-
tion events that shaped the A3 loci in horses. Thus, it is
highly likely that other Equidae, such as zebra and don-
key also present a horse-like A3 gene locus.
A3 genes in carnivora
Evidences of A3 genes can be found in the genome of
canids and felids. The A3Z3 gene is present in all carni-
vores genomes analysed, but the A3Z1 gene is missing
in Felidae and the A3Z2 gene is missing in Canidae (Fig-
ure 1, 3b). Both gene loss events must have occurred in-
dependently after the split between cat and dog lineages,
some 43–64 Mya. In the genome of the domestic cat (F.
catus) we identified four A3 genes (Z2a, Z2b, Z2c, and
Z3), while only one expressed A3Z2 and one A3Z3 gene
could be found in diverse species in the Panthera genus
[16]. The duplication events that generated the three
A3Z2 genes in the genome of the cat date 30 Mya (95%
HPD 13–48) and 14 Mya (95% HPD 4.7-30) (Figure 3b).
Although fine details in the evolution of felids are a mat-
ter of debate, the MRCA of Pantherinae and Felinae
could have lived some 12 Mya [49]. The fact that we
have found the A3Z2 gene in lion, tiger and leopard –all
of them Pantherinae- basal to the A3Z2 genes in cat,
puma and lynx –all of them Felinae- suggests that the
split between Pantherinae and Felinae predated the du-
plication events that generated the A3Z2 diversity in
cats. Further, three different mRNA sequences were
retrieved from lion and two from tiger [16]. If these
mRNA sequences originated from different genes this
would imply that independent gene duplications could
have occurred in the Panthera lineage. However, consid-
ering again the potential for multiple alternative splicingin the A3 genes, the analysis of genomic sequences is
required to determine whether panthers and cats have
found similar, convergent evolutionary answers to a se-
lective pressure that we still need to identify.
Evidences for selection in the evolution of A3 loci
The A3 genes of primates, rodents, felids, horses and
pigs have been described to be under a positive selection
[15,16,50-53]. We have searched for hints of positive se-
lection in the sequences in our dataset using Bayesian
inference. The AICDA gene, the sister taxon of the A3s,
showed to be under strict purifying selection while all
A3Z1, A3Z2 and A3Z3 genes contained residues under
positive selection (Table 1). Considering all sequences,
the distribution of Ka/Ks values was clearly multimodal
(Figure 4) for all three A3 genes, with around 25% of
positions under strict purifying selection, with Ka/Ks
values below 0.25, and above 10% of positions under
positive selection, with Ka/Ks values above 1.1. To ex-
clude that these results were driven by the sequences
gathered from Primates the calculations were repeated
after excluding them from the dataset, with a similar
outcome (Table 1). A slide-window analysis showed that
the Ka/Ks profiles were similar along the sequences of
the three genes (Figure 5), reflecting that the repertoire
of sites that are allowed to mutate and to explore se-
quence space are not evenly distributed and that to a
certain extent localise to similar positions in the three
A3Z1, A3Z2 and A3Z3 genes. Positions around codons
55 and 145 exhibit very low Ka/Ks values in all three A3
genes. There is a better coincidence of the Ka/Ks pro-
files in the C-terminus of the sequences analysed, while
there is ample variation in the first 100 codons of the
alignment, with A3Z1 and A3Z2 presenting islands of
increased the Ka/Ks values that do not always overlap.
The global distribution of Ka/Ks values in all sequences
is depicted in Figure 4, where the complexity of the dis-
tribution is evident, showing the existence of different
site levels of purifying selection, a large proportion of
sites evolving close to neutrality and a 10-20% of the
area below the curve corresponding to sites under diver-
sifying selection (Table 1).
Evolutionary rate has decreased in the three A3
subfamilies
The introduction of the variable time in the phylogenetic
analyses allows to identify variations of the evolutionary
rates in different taxa. The global mutation rate for our
sequences set was 1.6210-3 substitutions per site per My
(given as Huber M-estimator, Huber-M; median absolute
deviation, MAD, 1.0710-3). The evolutionary rates were
not homogeneous for the five gene families analysed
(one-way ANOVA, F ratio = 7.414, p < 0.0001). Regarding
the A1 genes the evolutionary rate is around 1.11 10-3
a
b
Figure 3 Projection of the A3 phylogenetic relationships onto the horse (a) and cat (b) genomic loci. Exon composition and gene
arrangement of the A3 genes are displayed. Labels indicate median age [95% HPD] of the corresponding nodes. Several milestones in the
evolution of mammals are indicated.
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this gene family there has been a significant decrease in
evolutionary rate with time (P= 0.00069, Figure 6a), but
it is mainly lead by the values sampled for the oldest
node at the root of the family. When this node is notincluded in the analyses, the evolutionary rate has not
significantly varied with time in the last 150 My
(P= 0.089, Figure 6a). The AICDA genes, the sister
group to A3s, displayed the lowest evolutionary rate
among the sequences studied (Huber-M 7.4110-4
Table 1 Statistics for the Ka/Ks values obtained either with the Mechanistic Empirical model (MEC) or with Random
Effects Likelihood (REL) estimates
All sequences Excluding primates sequences
A1 AICDA Z1 Z2 Z3 Z1 QZ2 Z3
MEC ka/ks quantil 25% 0.10 0.0067 0.29 0.26 0.19 0.44 0.26 0.15
median 0.40 0.036 0.90 0.88 0.65 0.92 0.8 0.61
quantil 90% 1.0 0.19 1.7 1.4 1.7 2.2 1.2 1.7
maximum value 1.9 0.34 3.6 3.8 2.4 3.5 2.6 2.4
REL dN-dS percentage of sites under positive|puryfying selection 5.4|34 0|100 1.0|15 7.5|14 5.0|12 2.0|8.2 16|13 6.8|12
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experienced changes with time in the last 400 My
(Figure 6a). All A3s however displayed increased evolu-
tionary rate values, around 2.5 times higher than the
AICDA sistergroup (Table 2). Very interestingly, the
evolutionary rate for each of the three A3 subfamilies
has significantly decreased in the last 100 My. For A3Z1
and A3Z3, the linear dependence with time explains a
large variation in the evolutionary rate, above 50% for
both genes (Figure 6b). In the case of the A3Z2 this de-
pendence is still significant but less obvious, and
explains less than 15% of the total variability in evolu-
tionary rate.
Discussion
A3 genes belong to a large superfamily of deaminases
that edit nucleic acids and constitute the sister taxa to
AICDA, as previous studies suggested [37,54]. Certain
members of the deaminase family, such as A1, target
RNA as a substrate, but it has been proposed that the
ancestral activity may have been to target DNA [54].
Our results show that the MRCA of AICDA and A3, ca
420 Mya, predates the split between the lineages of zebra
fish and humans. The subsequent duplication events of
the ancestral A3 gene to generate the three extant A3Z1,Figure 4 Histogram showing the distribution of the
percentages of Ka/Ks values for each position for the genes A1,
AICDA, A3Z1, A3Z2 and A3Z3 (colour code in the inset).A3Z2 and A3Z3 genes could not be dated with precision
and overlap largely. The first one occurred ca. 247 Mya
(95% HPD 193–351 Mya) and the second one ca. 199
Mya (95% HPD 164–251). Representatives of Laura-
siatheria, Euarchontoglires and Afrotheria are found in
all A3Z1, A3Z2 and A3Z3 subtrees. For Afrotherians, a
few sequences were found basal to the A3Z1 subgroup
(only sequences from the African bush elephant Loxo-
donta Africana), to the A3Z2 subgroup (the N-terminus
from L. Africana) or to the A3Z3 subgroup (an in silico
prediction from genomic DNA from the rock hyrax Pro-
cavia capensis and the C-terminus from one L. africana
sequence). On the view of the evolutionary relationships
and time divergences, we can conclude that the duplica-
tion events that originated the three ancestral A3 loci
had already occurred well before diversification within
placental mammals, which took place at some point be-
tween 95–120 Mya [55]. The presence of A3Z1 and
A3Z3 representatives in Afrotheria and of A3Z1, A3Z2
and A3Z3 in Boreoeutheria sustains also this view. The
estimated appearance of the most recent common an-
cestor of all A3s predates the split between placental
mammals and marsupials 125–150 Mya, and also the
split of monotremes at the base of the crown clade ofFigure 5 Slide window analysis showing the variation of Ka/Ks
along the corresponding sequence (colour code in the inset).
Values have been computed using a window of five positions and a
step of one.
Table 2 Evolutionary rates for the different large clades described measured as substitutions per site per million of
years, as inferred from the Bayesian time analyses
Evolutionary rate
(substitutions per site per My)
Evolution of the evolutionary rate






interval of the mean
Slope Standard error
all 1.62 10-3 1.07 10-3 1.97 10-3 4.31 10-4 – 6.44 10-3 NA NA
A1 1.11 10-3 A,B 5.86 10-4 1.15 10-3 4.49 10-4 – 2.29 10-3 5.15 10-6 1.7 10-6
AICDA 7.41 10-4 A 2.74 10-4 7.99 10-4 4.06 10-4 – 1.53 10-3 NS NS
A3Z1 1.79 10-3 B,C 9.88 10-4 2.14 10-3 7.49 10-4 – 6.50 10-3 4.15 10-5 4.4 10-6
A3Z2 2.06 10-3 C 1.28 10-3 2.60 10-3 4.52 10-4 – 7.61 10-3 3.34 10-5 9.4 10-6
A3Z3 2.13 10-3 C 1.38 10-3 2.15 10-3 4.17 10-4 – 4.40 10-3 2.61 10-5 4.7 10-6
Evolution of the evolutionary rate measured as variation of the substitution per site per (million of years)2. NA not analysed. NS correlation was not significant.
Values connected by the same letter are not significantly different after a Tukey-Kramer honestly significant difference test.
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and 203–238 Mya [57]. Thus, our data support an evolu-
tionary scenario where the genome of the MRCA of allFigure 6 Graph plotting the evolutionary rate against the node
age for (a) A1 and AICDA sequences and (b) A3Z1, A3Z2 and
A3Z3 sequences. Colour code in the inset. Values for the goodness
and significance of the fit to a straight line are provided. For the A1
genes, the values with and without the indicated point ($) are given.
When this value is not included in the analysis the trend is not
statistically significant.mammals already encoded for at least an ancestral A3,
and where the genome of the MRCA of all placental
mammals already encoded for a A3Z1-A3Z2-A3Z3 ar-
rangement. This genomic arrangement is conserved in
all placental mammals, with the A3 genes flanked by the
CBX6 and CBX7 genes, as in chromosome 22 q13.1 in
humans. This conserved chromosomic location could be
used for targeting and sequencing of the A3 locus of
selected species in the future. Unfortunately, the se-
quence gap between CBX6 and CBX7 is not resolved
with certainty in the opossum and in the platypus gen-
omes, and we cannot confirm whether the last common
ancestor of Eutheria and Metatheria already possessed a
single ancestral A3, the intermediate stage with two loci,
or already three loci, as the ancestor of all placental
mammals. A note of caution should be nevertheless sta-
ted here, since our results cannot go beyond the se-
quence dataset that we have been able to gather. In a
number of genomes we have not been able to recover any
relative of the A3 sequences. This holds true for Mono-
tremes, Marsupials and Xenarthra. For other organisms
we have not been able to detect certain A3 genes, such as
the A3Z1 gene in the cat genome and in Rodentia, or the
A3Z2 gene in the dog genome. Since for humans the exist-
ence of copy number variation in the A3A and A3B genes
is documented in a good number of cases (Additional file
4: Figure S3), a similar situation can be detected in the fu-
ture in other species. It is important to note here that
obtaining genomic sequences of the A3 locus is not trivial,
as it evolves under strong selective pressures [45]. In our
current analyses we have opted for the most parsimonious
explanation: e.g. the presence of an A3Z2 gene in Euarch-
ontoglires and in Felidae and the absence in Canidae has
been interpreted as the Boroeutherian ancestor carrying a
copy of the ancestral A3Z2 gene, which may had got lost
in the Canidae lineage. The hypothetical finding in the fu-
ture of an A3Z2 gene in Canidae would not affect our tim-
ing results as all calibrations have been chosen on subtrees
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cies (Additional file 5: Table S2).
The results here presented show that the A3 loci in
mammalian genomes are extremely variable and have
undergone independent events of gene duplication fol-
lowed by fixation, gene loss and gene fusion. The outcome
of these events has lead to parallel evolution, as is the case
of the loss of A3Z1 gene in rodents, dogs and pigs. The
most striking result, however, is that the amplification of
A3 genes and the fixation of duplicated genes has been
selected and expanded in the population, independently in
several taxa, such as the A3Z2 gene in Primates (Figure 2),
horses (Figure 3a) and cats (Figure 3b) and the A3Z1 gene
in Primates and horses. Further, an increase in the fre-
quency of duplication events in the last 50 Mya can be
observed in these three lineages, i.e. human, horse, cat (la-
belled with star symbols in Figure 1). Gene duplications
have occurred in both A3Z1 and A3Z2, but not in the
A3Z3 clade. Duplication of the A3Z3 gene seems thus to
be unfavoured, possibly reflecting the trade-off between
the advantages of an increased antiviral repertoire and the
increased self-toxicity by gene dosage effect [18]. Also
pointing in this direction, there is evidence for inde-
pendent events of A3Z3 activity loss in human alleles
[58]. Finally, further data that exemplify the broad
variability in the A3 locus come from copy number
variation studies in humans, with several reports on
the loss of the A3A (A3Z1a) and/or the A3B (A3Z2a-
A3Z1b) genes (Additional file 4: Figure S3).
Different taxa have selected similar solutions through
independent events in the A3 locus in terms of gene
duplications and/or deletions. Such parallel evolution
may be the response to similar environmental changes,
e.g. increased retroviral activity either exogenous or en-
dogenous, which could account for the parallel expan-
sion of the A3 family in different mammalian clades.
The fixation of similar duplication events in different
lineages suggests that the preservation of the duplicated
genes has a positive effect in fitness. Further, the main
activity of all A3 genes seems to be ssDNA editing, and
the differences among them are rather related to sub-
strate specificity [59,60], expression pattern [61,62], and
virus specificity [2]. The fate of new A3 copies may thus
be sub-functionalisation by broadening the spectrum of
molecular targets that can be edited by the A3 proteins,
and that this fine tuning of the edited DNA substrates
results in an increase in fitness. Such shift in substrate
specificity is also supported by the evidence of positive
selection in A3s in primates, rodents, felids, horses
[16,50-53,63], and our results confirm as well the pres-
ence of residues under positive selection in all A3Z1,
A3Z2 and A3Z3 clades (Table 1). However, the antiviral
relevance of the differential deaminase activity as a func-
tion of the ssDNA sequence still needs to be explored.Our results show that residues evolving under neutrality
co-occur with residues under positive and under purifying
selection in the A1 and in the A3 genes, and that this
holds true for all sequences considered together even after
accounting for the excess of Primates sequences (Table 1
and Figure 4). For all these genes, there is a clear peak and
a substantial proportion of sites evolving close to neutral-
ity. Additionally, a substantial amount of area below the
curve is located in the two tails of the multimodal distri-
bution, corresponding to positions evolving under strict
purifying selection and intermediate values of 0.5 <Ka/
Ks< 0.8, and under positive selection. Previous descrip-
tions had rather focused on specific genes in specific taxa,
i.e. primates, rodents, horses, felids and pigs [16,50-53,63].
Our analyses have addressed the three A3 gene clusters in
all mammals and show that multiple evolutionary pres-
sures coexist in the same gene sequence. Similar cases of
positive selection observed as an increase of Ka/Ks during
subfunctionalisation of duplicated genes has been also
documented in other gene families [64]. The biological in-
terpretation of the significance of individual residues under
positive selection needs to be analysed in the context of
the evolution of the gene in which they reside and in the
biochemical context of the exon combination present in
the actually expressed proteins. Methods for detecting
positive selection based on Ka/Ks ratios may result in false
positives, as a relaxation of evolutionary constraints could
also lead to an increase in this parameter [65]. Such con-
straint relaxation is specially expected to occur in genes
that have undergone duplication events, as it is the case in
the A3 genes. Thus, the actual meaning of sites under posi-
tive selection in the three A3Z1, A3Z2 and A3Z3 clades
requires experimental confirmation. Additionally, gene du-
plication could be the result of the genomic arms race be-
tween target viruses and their hosts, as novel A3 proteins
can counteract anti-antiviral activity raised in a virus that
evolves anti-A3 mechanisms, such as the Vif or the Bet
protein [19-22,24]. This combination could correspond to
certain models among those proposed by Innan and Kon-
drashov [40] to classify the evolution of duplicated genes,
such as modified duplication or diversifying selection. The
evolution of the A3Z2 locus in primates, horse and cat,
with several rounds of successive amplification events, sug-
gests however that gene duplication may have occurred
here through an adaptive radiation model, as proposed by
Francino [66]. The new A3 copies could explore the se-
quence space that expands the family of substrates for the
action of deaminases, typically by modifying the sequence
context of the C- >U edition. Similarity among duplicated
genes could also allow for gene conversion and/or recom-
bination [67], further enlarging the repertoire of substrates.
In analogy to gene conversion at the DNA level, similarity
in DNA sequence between tandem duplicated genes may
be responsible for the read-through mRNA species that
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described in cats [16,68], horses [27] and pigs [15,47] and
have also been communicated in humans [69] (Additional
file 6: Figure S4). Currently more than 500 ESTs in the data-
bases map onto the A3 human loci, with a number of them
containing spliced exons from different A3 genes (Add-
itional file 6: Figure S4). This additional generation of diver-
sity adds to the high number of alternatively spliced mRNAs
originated from each individual A3 gene, especially of those
composed of two fused “mono” A3s, either A3Z2-A3Z1 or
A3Z2-A3Z2. In these cases we face fused genes that retain
their individual coding capacity, can generate multiple splice
alternatives and show potential to encode for read-through
mRNAs. Finally, an additional level of spatiotemporal com-
plexity to the regulation of this antiviral activity arises from
A3 expression heterogeneity linked to cell type, tissue, devel-
opmental time or exposure to foreign DNA.
The architecture of several tandem copies of paralogs
in a genome facilitates non-homologous recombination
among paralog copies resulting in gene conversion, as
has been suggested for the A3G gene in humans [67]. A
high degree of gene conversion is expected to result in
an increased degree of sequence similarity through con-
certed evolution [70,71], with the undesired outcome of
rendering younger divergence times [72]. Our dataset is
unfortunately not suited for an in-depth analysis of gene
conversion, since it includes well-characterised mRNAs,
but also ESTs that may contain exons that originate
from different genes and putative mRNAs inferred from
genomic sequences. A proper analysis will need good
quality genomic sequences with enough sampling of
individuals if variations found in the human A3 locus in
terms of gene copy number and indels (Additional file 4:
Figure S3 and Additional file 6: S4) appear also in other
species. Such analyses will need to address gene order
within the locus, but also exon-intron order within the
genes, and alternative splicing and mRNA read-through.
Nevertheless, certain cases can be considered. The con-
founding role of gene conversion may have disturbed
the phylogenetic reconstructions for the A3Z2 genes. In
Primates, the A3Z2a, A3Z2c and A3Z2e A3Z2g paralogs
have appeared after two duplication events from their
common ancestor around 73 Mya (Figure 2). The top-
ology for the A3Z2g subtree matches well the phylogeny
of the corresponding species (Additional file 2: Figure
S1), and gene conversion may have had a limited impact
here. The evolution of the A3Z2a, A3Z2c and A3Z2e
genes however cannot be reconstructed with confidence,
and appears as a series of small branches with small sup-
port values, which could be interpreted as a signature of
gene conversion. The same holds true for the rest of the
A3Z2 paralogs, A3Z2b/d/f. Finally, a second candidate
for gene conversion to have occurred is the A3Z2a/b
gene tandem in the cat genome [16].The AICDA genes show the lowest evolutionary rate
among the five clades studied, 1.11 10-3 substitutions per
site per My, significantly different from the values in-
ferred for the three A3 genes, which are around three
times higher (Table 2). Very interestingly, we have found
that these evolutionary rates have decreased for the A3
genes in the last 100 My, whereas for the AICDA and
the A1 genes there are no significant variations in the
evolutionary rate with time (Table 2). We interpret the
different outcome for the A3 genes and for their sister
taxa as an evidence for our results being genuine rather
than an artefact from the evolutionary inference. The
simultaneous identification of positions evolving under
positive selection in the three A3 genes and the finding
of a trend towards decrease with time of the evolution-
ary rate in the same genes are not contradictory. Our
calculations for Ka/Ks have been performed separately for
each position, while the values inferred for the evolution-
ary rates refer to the corresponding nodes in the phylo-
genetic reconstruction. In our scenario of gene duplication
and gene family expansion, we interpret that the episodes
of gene duplication have lowered the restrictions on the
duplicated copies of the genes, thus allowing for increased
evolutionary rates. Subfunctionalisation of the sister copies
may have yielded one population of conserved sites evolv-
ing under purifying pressures (e.g. those sites that are in-
dispensable for the deaminase activity), one population of
sites positively selected sites (e.g. those that are responsible
for the differential substrate recognition) and a third large
majority of sites evolving close to neutrality. The decrease
in evolutionary rate possibly reflects a plateau in the fix-
ation of the novel function. In the A3Z2 genes, which have
undergone the largest number of duplication events, the
large variation in evolutionary rate for the different nodes
(Table 2) and the lower proportion of the decrease in evo-
lutionary rate that is explained by the independent variable
time alone (less than 15%; Figure 6b) supports further the
idea that gene duplication fosters a transient increase in
evolutionary rate.
We have not been able to identify in the databases
sequences that could be orthologs of the A3 genes in Mar-
supials or in Monotremes. We have dated the MRCA of
the A3 genes around 246 Mya (95% HPD 192–351 Mya),
and the second split that generated the MRCA of A3Z1
and A3Z2 around 199 Mya (95% HPD 164–250). The tim-
ing for the crown clade of mammals (i.e. the split between
Monotremata and Theria) as well as the timing for the
split between marsupials and placentals are controversial,
ranging between 160 and 240 Mya [55-57]. Three explana-
tions could thence account for the absence of extant A3
genes in monotremes and marsupials: i) we simply lack in-
formation and further sequencing will provide us with the
missing genes; ii) members of one or of both groups may
indeed have lost the A3 genes; and iii) genes may be
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predates the appearance of the MRCA of all A3s. Our in-
terpretation implies in any case that the genome of the
placental ancestor already encoded for an A3 locus with
the arrangement A3Z1-A3Z2-A3Z3. The absence of A3
genes in Xenarthra, the fourth large clade within placental
mammals, must therefore imply either gene loss or incom-
plete coverage of the A3 locus in the two species analysed.
Since we have described that loss of certain A3 genes has
occurred in parallel in different lineages, as in Rodents
and in Artyodactyla, it is conceivable that in certain
lineages the loss of all A3 genes may have been selected.
The adaptive value of an enlarged armoury against viruses
is obvious, and evidences supporting positive selection of
the A3 genes in different branches of the mammalian tree
are strong. The intriguing hypothesis of the total local loss
of A3 genes might imply that the constraints and pres-
sures imposed by viral infections can largely vary among
different taxa. Certain host lineages may thus either be less
exposed to (certain) viruses, and/or may have evolved al-
ternative antiviral strategies. An exciting question that
arises from our dating results is the relative coincidence in
time between speciation events and gene duplication
events, as exemplified in Figures 2 and 3. It could be
speculated that gene duplication of the A3 genes may trig-
ger speciation, possibly through the differential fitness
against viral infections that the additional A3 gene copy
provides. Further genetic and functional research will be
required to elucidate the fitness landscapes integrating
viral pressures, expansion of the A3 repertoire and con-
comitant risks for the own genetic information.
Conclusions
The A3 gene family appeared together with the ancestral
mammals. Independently in certain lineages, the A3 locus
was expanded through a series of tandem duplications,
best exemplified in Primates. The repertoire of A3 pro-
teins is additionally expanded through splice alternatives
and read-through mechanisms, resulting in broader sub-
strate specificity and finer regulation of DNA modification
potential. We have shown that this diversity has been gen-
erated by series of tandem duplication in the A3 locus
probably followed by positive selection and/or relaxation
of constraints and resulting in sub/neo-functionalisation.
Such evolutionary solution has been independently
selected in several lineages: Primates, felids and equids.
Our findings constitute a paradigm of genomic parallel
evolutionary solutions in the framework of the arms race
between viruses and their hosts.
Methods
Dataset
Annotated sequences were retrieved from GenBank and
Ensembl Genome Browser, the data set was completedwith cDNA sequences and with genomic sequences puta-
tively encoding for products similar to A3 after iterative
BLAT, tBLASTn and PSI-BLAST searches. Our final data-
set included sequences from within Laurasiatheria (seven
Carnivora, seven Cetartiodactyla, one Perissodactyla and
one Chiroptera species), Euarchontoglires (three Rodentia
and seventeen Primates species) and Afrotheria (one Hyr-
acoidea and one Proboscidea species). Fused genes as in
human A3Z2a-A3Z1b were split and analysed as two
sequences.
A selection of 24 APOBEC1 (A1) sequences (21 Eu-
theria species, two Metatheria and one Aves species)
and 34 Activation induced cytidine deaminases (AICDA)
sequences (23 Eutheria species, three Metatheria, one
Prototheria, two Aves, two Amphibia and three Actinop-
terygii species) and were used as outgroups. The final se-
quence set comprised 202 sequences. A list of species
and accession numbers is given in Additional file 1:
Table S1.
Phylogenetic inference
Sequences were aligned with MAFFT (http://mafft.cbrc.
jp/alignment/software/) at the amino acid level and
back-translated into nucleotides for phylogenetic ana-
lyses. This matrix is available as Additional file 7 and
from IGB on request. Maximum likelihood (ML) infer-
ence was performed with RAXML_v7.2.8 (http://www.
exelixis-lab.org/) [73] using 5000 bootstrap cycles with
the GTR+G4 model and introducing three partitions,
one per codon position (number of patterns 290, 290
and 298, respectively) and allowing for different total
tree length for each partition. Bayesian inference was
performed with PHYLOBAYES v3.3 (http://www.phylo-
bayes.org) [74] using the same dataset, under the GTR
model, removing constant sites, running two independ-
ent chains and checking for convergence comparing dis-
crepancies among partitions. Trees obtained after ML
and Bayesian reconstructions were compared regarding
topological congruence as well as pairwise distances
using K-TreeDist [75], with the following result:
Robinson-Foulds distance, 67/401 (16.7%); K-score, 1.07;
scale factor, 0.542. Both ML and Bayesian topologies
rendered A3Z1, A3Z2 and A3Z3 as monophyletic, and
A1 as the outgroup to A3s and AICDA. Twenty-five
local topologies, highly supported in both analyses
(above 90% bootstrap support and above 0.98 Bayesian
posterior probability) and consistent with the phylogen-
etic relationships of the hosts were identified and used
for molecular dating, using truncated uniform priors
based on fossil calibration dates, as suggested by Benton
and Donaghue [56,76]. Calibration dates are listed in
Additional file 5: Table S2. All discussion on the results
obtained refers to the dates and analyses proposed by
TimeTree (http://www.timetree.org/index.php) [77]. The
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RAxML v7.2.8 with the same settings as described above,
further forcing monophyly for each of the nodes used for
calibration (−g option), plus for the sequences belonging to
the crowngroups Afrotheria, Laurasiatheria and Euarchon-
toglires within each of the clades A1, AICDA, A3Z1, A3Z2
and A3Z3, respectively. This tree was not significantly
worse than the original one, under the maximum-
likelihood framework, as evaluated with a Shimodaira-
Hasegawa test [78] implemented in RAxML v7.2.8. The
comparison between the unconstrained and the con-
strained maximum likelihood trees rendered the following
values: Robinson-Foulds distance, 71/401 (17.7%); K-score;
0.780; scale factor, 0.823. Using this tree, Bayesian time in-
ference was performed with PHYLOBAYES v3.3 using a
discrete gamma distribution with eight categories under
the GTR matrix of exchange rates, using a log-normal
autocorrelated relaxed clock together with a uniform prior
on divergence times. A gamma prior of mean 550 and
standard deviation 200 Mya was specified for the age of
the root. The results from three 50-million steps independ-
ent chains were combined and analysed.
Positive selection analysis
Evidence for positive selection was analysed in a Bayesian
framework using SELECTON V2.4 (http://selecton.tau.ac.
il/) and DATAMONKEY (http://www.datamonkey.org/).
The alignments for the A1, AICDA, A3Z1, A3Z2and A3Z3
genes were analysed separately for the whole sequence set,
and those for A3Z1, A3Z2 and A3Z3 were additionally
analysed after excluding the Primates sequences, to discard
that the results were driven by the behaviour of sequences
from this clade. With SELECTONV2.4, the Mechanistic
Empirical Model (MEC) was tested against the M8a model
[79]. In both cases the topology of the best-known max-
imum likelihood tree previously obtained was used as scaf-
fold for the calculation of synonymous Ks and non-
synonymous Ka mutations. Briefly, MEC expands an em-
pirical amino acid replacement matrix –in our case the
WAG matrix [80], the best scoring one as determined by
ProtTest [81] among those available in the SELECTON
algorithm- into a codon replacement matrix. This way, the
chemical similarity between amino acids is incorporated
when calculating non-synonymous substitutions [79]. The
likelihood of this model was tested against the M8a model,
which does not allow for positive selection, using the
Akaike information criterion [82]. For all of the sequence
sets the MEC model was preferred over the M8a. For each
position, the value for Ka/Ks was calculated. The variation
of Ka/Ks along the corresponding sequence was analysed
using a slide-window analysis of width five and step one.
With DATAMONKEY, the Random Effects Likelihood
(REL) method was applied, which assumes an underlying
nucleotide substitution model and allows for rate variationin both Ka and Ks substitution rates [83]. All analyses were
repeated after excluding the Primates sequences from the
dataset, in order to exclude putative biases inherent to the
overrepresentation of this clade in terms of sequence com-
position and presence of the different genes in the genome.
Statistic analyses were performed with R v1.40 and with
JMP v7.0.2.
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